PFS Triumph or OS Flop? Why CMPX Shares Plunged Despite Positive Cancer Results
Compass Therapeutics fell after cancer drug improved outcomes but failed to show clear survival benefit due to patient crossover.
NOTRELOAD AI
Microsoft & OpenAI Just Rewrote Their Partnership: More Freedom, Less Drama
Microsoft and OpenAI updated deal: OpenAI gets more freedom, Azure remains main partner, revenue rules simplified, AGI clause removed.
Veradermics’ Oral Hair Loss Pill Scores Major Win in Late-Stage Trial
Veradermics’ hair pill VDPHL01 showed strong results, growing 30+ hairs/cm in trials, safe, and may become a new baldness treatment.
Oruka’s Long-Acting Psoriasis Drug Hits 63.5% Complete Skin Clearance in Mid-Stage Trial
Oruka’s new psoriasis drug cleared skin in most patients with few side effects and may need only yearly injections.
Shell Buys ARC Resources for $16.4 Billion in Major Canadian Shale Deal
Shell will buy ARC Resources for $16.4B, boosting oil & gas output and reserves, aiming for cost savings and growth.
Domino’s Pizza Q1 2026: Same-Store Sales Miss Expectations as Customers Tighten Budgets
Domino’s sales were mixed, profits fell, but stores grew and deals helped boost orders despite weak economy concerns.